Danske Bank’s Vicarious Surgical RBOT Stock Holding History

Danske Bank’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$13	–	1443
2024 Q4	$13	Hold	1	–	–	﹤0.01%	1339
2024 Q3	$6	Buy	+1	New	+$7	﹤0.01%	1547

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Danske Bank's RBOT Position: Q1 2025 in Review

Danske Bank sold out of Vicarious Surgical (RBOT) in Q1 2025, closing a stake of 1 share — an estimated $13 sold.

Danske Bank first reported a position in RBOT in Q3 2024 and held it in 2 quarters. The position peaked at $13 in Q4 2024. 31 funds tracked by Wall St. Rank hold RBOT as of Q1 2025.

Danske Bank reported no remaining Vicarious Surgical position as of Q1 2025 after selling out during the quarter.
Danske Bank sold 1 Vicarious Surgical share in Q1 2025, an estimated $13.
Danske Bank first reported a position in Vicarious Surgical in Q3 2024 and held it in 2 quarters.
Danske Bank's Vicarious Surgical position peaked at $13 in Q4 2024.
31 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2025.

Based on Danske Bank's 13F filing for Q1 2025, filed 18 Dec 2025.